+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Monkeypox Rapid Test Kit Market - Global Forecast 2026-2032- Product Image
Monkeypox Rapid Test Kit Market - Global Forecast 2026-2032- Product Image
Sale

Monkeypox Rapid Test Kit Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6120712
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Monkeypox Rapid Test Kit Market is projected to reach USD 476.56 Million in 2026. It is expected to continue growing at a CAGR of 7.33%, reaching USD 721.05 Million by 2032.

Monkeypox Rapid Test Kits: Executive Summary

Monkeypox-also known as mpox-rapid test kits support the timely identification of suspected infections and help guide isolation, contact tracing, treatment decisions, and public-health surveillance. Their role is shaped by diagnostic accuracy, specimen requirements, turnaround time, regulatory authorization, laboratory capacity, and integration with broader outbreak-response systems. Demand conditions vary by transmission patterns, public-health protocols, procurement systems, and access to confirmatory testing.

Public-Health Systems Are Reframing Rapid Diagnostic Readiness

The diagnostic landscape is shifting from emergency deployment toward sustained preparedness. Health systems are emphasizing validated assays, dependable supply chains, quality management, biosafety, clinician training, and clear referral pathways for confirmatory testing. Rapid formats can improve triage and operational responsiveness, but their value depends on appropriate specimen collection, validated performance, transparent labeling, and alignment with national and international guidance.

Procurement is also becoming more risk-sensitive. Buyers increasingly assess evidence quality, interoperability with laboratory workflows, reagent stability, distribution resilience, and the ability to support decentralized settings without weakening quality assurance. Regulatory pathways and post-market surveillance remain central to responsible adoption.

Artificial Intelligence Strengthens Triage, Surveillance, and Quality Control

Artificial intelligence can support the surrounding diagnostic ecosystem rather than replace validated testing. Potential applications include prioritizing suspected cases, identifying unusual clusters from surveillance data, optimizing specimen logistics, assisting image or result interpretation where appropriate, and detecting quality anomalies in laboratory operations. These uses require representative datasets, external validation, cybersecurity controls, and clear human oversight.

AI-enabled tools should not be treated as evidence of diagnostic performance by themselves. Public-health programs must distinguish algorithmic triage from pathogen detection, monitor false-positive and false-negative risks, protect sensitive health information, and ensure that automated recommendations remain explainable to clinicians and health authorities.

Regional Priorities Differ Across North America, Latin America, Europe, Middle East, Africa, and Asia-Pacific

North America generally benefits from established laboratory networks, regulatory infrastructure, and surveillance capabilities, while access and coordination can differ across jurisdictions. Latin America faces the need to strengthen decentralized testing, procurement continuity, reporting, and links between community services and reference laboratories. Europe combines strong public-health coordination with varied national procurement and laboratory arrangements.

The Middle East is balancing centralized health systems, cross-border mobility, and preparedness for imported or localized transmission. Africa’s priorities include affordable access, workforce development, specimen transport, quality assurance, and integration with broader infectious-disease surveillance. Asia-Pacific presents substantial diversity: advanced systems can focus on rapid deployment and interoperability, while lower-resource settings may prioritize resilient supply chains, training, and access to confirmatory capacity.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Highlight Coordination Needs

ASEAN members benefit from stronger regional information sharing, compatible surveillance practices, and coordinated procurement approaches that account for different health-system capacities. BRICS participants span varied regulatory and laboratory environments, making mutual learning, dependable manufacturing inputs, and adaptable implementation important. The European Union benefits from cross-border coordination while retaining national differences in testing pathways and purchasing.

G7 countries are positioned to support evidence generation, standards development, global preparedness, and equitable access, while avoiding fragmented emergency procurement. GCC members can emphasize coordinated purchasing, workforce readiness, and regional referral networks. NATO members may also consider continuity of diagnostic operations during emergencies, infrastructure disruption, and cross-border public-health coordination, while keeping clinical governance central.

Country-Level Needs Reflect Diverse Surveillance and Diagnostic Capacities

Australia, Japan, South Korea, Canada, the United States, the United Kingdom, France, Germany, Italy, and Spain generally have established public-health and laboratory structures, but they still require sustained readiness, validated products, and consistent reporting across jurisdictions. Their priorities include integrating rapid testing with reference-laboratory confirmation, maintaining clinician awareness, and ensuring equitable access beyond major urban centers.

Brazil, Mexico, India, China, and Russia represent diverse geographic, regulatory, and health-system contexts. Key considerations include decentralized specimen collection, reliable distribution, workforce training, culturally appropriate outreach, transparent performance evidence, and coordination between national and subnational authorities. Across all listed countries, implementation should reflect local epidemiology and official guidance rather than relying on a single testing model.

Industry Leaders Should Prioritize Evidence, Resilience, and Responsible Deployment

Leaders should first establish a clear intended use, target population, specimen type, testing setting, and pathway for confirmatory diagnosis. Product decisions should be based on independently reviewed performance evidence, applicable regulatory status, usability studies, stability data, and post-market monitoring. Procurement teams should evaluate total operational requirements, including equipment, training, waste management, logistics, data capture, and quality controls.

Organizations should build partnerships with public-health authorities and reference laboratories, maintain diversified supply arrangements, and prepare surge plans that avoid unnecessary stock accumulation. Digital and AI capabilities should be introduced only with privacy safeguards, cybersecurity protections, bias assessment, and human review. Equitable deployment requires attention to rural communities, vulnerable populations, affordability, language access, and continuity of care.

Research Methodology for the Executive Summary

This executive summary uses a structured qualitative framework focused on the role of monkeypox rapid test kits in clinical triage, surveillance, outbreak preparedness, procurement, regulation, and health-system operations. The assessment organizes findings across the required regions, country groupings, and countries, while considering differences in laboratory infrastructure, public-health governance, access, and implementation conditions.

Evidence should be interpreted through authoritative sources such as public-health agencies, regulatory authorities, peer-reviewed diagnostic studies, laboratory guidance, and international health organizations. Claims are limited to verifiable strategic observations. No market estimates, market sizes, market shares, forecasts, or company-specific assessments are included.

Preparedness and Diagnostic Quality Will Define Sustainable Adoption

Monkeypox rapid test kits can contribute to faster public-health action when they are accurate, appropriately authorized, operationally feasible, and connected to confirmatory testing and surveillance. Their effectiveness is not determined by speed alone; it depends on quality assurance, trained personnel, resilient supply chains, responsible data use, and equitable access.

The strongest strategies combine validated diagnostics with coordinated preparedness across regions, country groups, and national systems. Industry leaders and public-health stakeholders should therefore focus on evidence-based deployment, interoperable reporting, transparent performance monitoring, and readiness that can be sustained beyond individual outbreaks.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Monkeypox Rapid Test Kit Market, by Test Technology
7.1. Introduction
7.2. Lateral Flow Immunoassay
7.2.1. Visual Read
7.2.2. Reader-based
7.3. Isothermal Nucleic Acid Amplification
7.3.1. Loop-mediated Amplification
7.3.2. Recombinase Polymerase Amplification
7.4. Rapid Polymerase Chain Reaction
7.4.1. Cartridge-based System
7.4.2. Open System Kit
7.5. CRISPR-based Detection
7.5.1. Cas12 Assay
7.5.2. Cas13 Assay
8. Monkeypox Rapid Test Kit Market, by Sample Type
8.1. Introduction
8.2. Lesion Swab
8.2.1. Vesicle Fluid
8.2.2. Crust Material
8.3. Oropharyngeal Swab
8.4. Nasopharyngeal Swab
8.5. Saliva
8.6. Whole Blood
8.6.1. Fingerstick Capillary
8.6.2. Venous Draw
8.7. Serum or Plasma
9. Monkeypox Rapid Test Kit Market, by Distribution Channel
9.1. Introduction
9.2. Direct Institutional Sales
9.3. Group Purchasing Organization Contracts
9.4. Wholesalers and Distributors
9.5. Retail Pharmacies
9.6. Online Pharmacies
9.7. E-commerce Marketplaces
9.8. Non-profit and Donor-funded Procurement
10. Monkeypox Rapid Test Kit Market, by Application
10.1. Introduction
10.2. Clinical Diagnosis
10.3. Screening and Surveillance
10.3.1. Community Screening
10.3.2. High-risk Population Screening
10.3.3. Travel and Border Screening
10.4. Outbreak Management
10.4.1. Case Confirmation
10.4.2. Contact Tracing Support
10.5. Research Use
11. Monkeypox Rapid Test Kit Market, by End User
11.1. Introduction
11.2. Hospitals
11.2.1. Public Hospitals
11.2.2. Private Hospitals
11.3. Clinics
11.3.1. Primary Care Clinics
11.3.2. Sexual Health and Dermatology Clinics
11.4. Diagnostic Laboratories
11.4.1. Independent Reference Laboratories
11.4.2. Public Health Laboratories
11.5. Ambulatory Surgical Centers
11.6. Pharmacies
11.7. Occupational Health Providers
11.8. Non-governmental Organizations
11.9. Research and Academic Institutes
12. Monkeypox Rapid Test Kit Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Monkeypox Rapid Test Kit Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Monkeypox Rapid Test Kit Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. ACON Biotech Co., Ltd.
16.3. Altona Diagnostics GmbH
16.4. Becton, Dickinson and Company
16.5. Beijing Hotgen Biotech Co., Ltd.
16.6. BGI Group
16.7. BioChain Science-Technology, Inc.
16.8. Bioperfectus Technologies Co., Ltd.
16.9. DaAn Gene Co., Ltd.
16.10. Guangzhou Wondfo Biotech Co., Ltd.
16.11. Joysbio Biotechnology Co., Ltd.
16.12. Novacyt S.A.
16.13. Revvity, Inc.
16.14. Roche Diagnostics
16.15. Sansure Biotech Inc.
16.16. Shanghai ZJ Bio-Tech Co., Ltd.
16.17. Siemens Healthineers AG
16.18. Thermo Fisher Scientific Inc.
16.19. Trivitron Healthcare Pvt. Ltd.
16.20. Zhejiang Orient Gene Biotech Co., Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Monkeypox Rapid Test Kit Market, Years Considered for the Study
FIGURE 2. Global Monkeypox Rapid Test Kit Market, Research Design
FIGURE 3. Global Monkeypox Rapid Test Kit Market, Research Framework
FIGURE 4. Global Monkeypox Rapid Test Kit Market, Data Triangulation
FIGURE 5. Global Monkeypox Rapid Test Kit Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Monkeypox Rapid Test Kit Market Size, by Test Technology, 2025 vs 2032 (%)
FIGURE 7. Global Monkeypox Rapid Test Kit Market Size, by Test Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Monkeypox Rapid Test Kit Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 9. Global Monkeypox Rapid Test Kit Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Monkeypox Rapid Test Kit Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Monkeypox Rapid Test Kit Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Monkeypox Rapid Test Kit Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Monkeypox Rapid Test Kit Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Monkeypox Rapid Test Kit Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Monkeypox Rapid Test Kit Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Monkeypox Rapid Test Kit Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Monkeypox Rapid Test Kit Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Monkeypox Rapid Test Kit Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Monkeypox Rapid Test Kit Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Monkeypox Rapid Test Kit Market Segmentation & Coverage
TABLE 2. Global Monkeypox Rapid Test Kit Market Size, 2017-2032 (USD Million)
TABLE 3. Global Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 4. Global Lateral Flow Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Lateral Flow Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Lateral Flow Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Visual Read Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Visual Read Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Visual Read Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Reader-based Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Reader-based Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Reader-based Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Isothermal Nucleic Acid Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Isothermal Nucleic Acid Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Isothermal Nucleic Acid Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Loop-mediated Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Loop-mediated Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Loop-mediated Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Recombinase Polymerase Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Recombinase Polymerase Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Recombinase Polymerase Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Rapid Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Rapid Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Rapid Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Cartridge-based System Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cartridge-based System Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cartridge-based System Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Open System Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Open System Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Open System Kit Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global CRISPR-based Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global CRISPR-based Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global CRISPR-based Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cas12 Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Cas12 Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Cas12 Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Cas13 Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Cas13 Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Cas13 Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 41. Global Lesion Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Lesion Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Lesion Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Vesicle Fluid Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Vesicle Fluid Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Vesicle Fluid Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Crust Material Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Crust Material Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Crust Material Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Oropharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Oropharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Oropharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Nasopharyngeal Swab Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Nasopharyngeal Swab Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Nasopharyngeal Swab Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Fingerstick Capillary Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Fingerstick Capillary Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Fingerstick Capillary Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Venous Draw Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Venous Draw Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Venous Draw Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Serum or Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Serum or Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Serum or Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 72. Global Direct Institutional Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Direct Institutional Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Direct Institutional Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Group Purchasing Organization Contracts Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Group Purchasing Organization Contracts Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Group Purchasing Organization Contracts Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Wholesalers and Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Wholesalers and Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Wholesalers and Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global E-commerce Marketplaces Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global E-commerce Marketplaces Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global E-commerce Marketplaces Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Non-profit and Donor-funded Procurement Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Non-profit and Donor-funded Procurement Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Non-profit and Donor-funded Procurement Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. Global Clinical Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Clinical Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Clinical Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Screening and Surveillance Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Screening and Surveillance Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Screening and Surveillance Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Community Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Community Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Community Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global High-risk Population Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global High-risk Population Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global High-risk Population Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Travel and Border Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Travel and Border Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Travel and Border Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Outbreak Management Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Outbreak Management Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Outbreak Management Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Case Confirmation Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Case Confirmation Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Case Confirmation Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Contact Tracing Support Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Contact Tracing Support Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Contact Tracing Support Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Research Use Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Research Use Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Research Use Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Primary Care Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Primary Care Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Primary Care Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Sexual Health and Dermatology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Sexual Health and Dermatology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Sexual Health and Dermatology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Independent Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Global Independent Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. Global Independent Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 146. Global Public Health Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 147. Global Public Health Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. Global Public Health Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 152. Global Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 153. Global Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 154. Global Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 155. Global Occupational Health Providers Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Global Occupational Health Providers Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. Global Occupational Health Providers Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. Global Non-governmental Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. Global Non-governmental Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. Global Non-governmental Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 161. Global Research and Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Global Research and Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 163. Global Research and Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. Global Monkeypox Rapid Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 174. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 176. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 177. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 178. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 180. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 181. Asia-Pacific Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 182. North America Monkeypox Rapid Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. North America Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 184. North America Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 185. North America Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 186. North America Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 187. North America Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 188. North America Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 189. North America Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 190. North America Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 191. North America Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. North America Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. North America Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 194. North America Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 195. North America Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. North America Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 197. North America Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 198. North America Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 199. Latin America Monkeypox Rapid Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Latin America Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 201. Latin America Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 202. Latin America Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 203. Latin America Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 204. Latin America Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 205. Latin America Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 206. Latin America Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 207. Latin America Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 208. Latin America Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. Latin America Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 210. Latin America Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 211. Latin America Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 212. Latin America Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 213. Latin America Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 214. Latin America Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 215. Latin America Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 216. Europe Monkeypox Rapid Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Europe Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 218. Europe Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 219. Europe Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 220. Europe Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 221. Europe Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 222. Europe Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 223. Europe Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 224. Europe Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 225. Europe Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 226. Europe Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Europe Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 228. Europe Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 229. Europe Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Europe Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 231. Europe Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 232. Europe Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 233. Middle East Monkeypox Rapid Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 234. Middle East Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 235. Middle East Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 236. Middle East Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 237. Middle East Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 238. Middle East Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 239. Middle East Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 240. Middle East Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 241. Middle East Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 242. Middle East Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. Middle East Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Middle East Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 245. Middle East Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 246. Middle East Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 247. Middle East Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 248. Middle East Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 249. Middle East Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 250. Africa Monkeypox Rapid Test Kit Market Size, by Region, 2017-2032 (USD Million)
TABLE 251. Africa Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 252. Africa Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 253. Africa Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 254. Africa Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 255. Africa Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 256. Africa Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 257. Africa Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 258. Africa Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 259. Africa Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 260. Africa Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 261. Africa Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 262. Africa Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 263. Africa Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 264. Africa Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 265. Africa Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 266. Africa Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 267. Global Monkeypox Rapid Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. ASEAN Monkeypox Rapid Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. ASEAN Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 270. ASEAN Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 271. ASEAN Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 272. ASEAN Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 273. ASEAN Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 274. ASEAN Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 275. ASEAN Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 276. ASEAN Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 277. ASEAN Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 278. ASEAN Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 279. ASEAN Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 280. ASEAN Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 281. ASEAN Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. ASEAN Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 283. ASEAN Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 284. ASEAN Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 285. GCC Monkeypox Rapid Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 286. GCC Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 287. GCC Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 288. GCC Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 289. GCC Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 290. GCC Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 291. GCC Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 292. GCC Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 293. GCC Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 294. GCC Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 295. GCC Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 296. GCC Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 297. GCC Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 298. GCC Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. GCC Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 300. GCC Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 301. GCC Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 302. European Union Monkeypox Rapid Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 303. European Union Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 304. European Union Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 305. European Union Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 306. European Union Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 307. European Union Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 308. European Union Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 309. European Union Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 310. European Union Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 311. European Union Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 312. European Union Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. European Union Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 314. European Union Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 315. European Union Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. European Union Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 317. European Union Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 318. European Union Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 319. BRICS Monkeypox Rapid Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 320. BRICS Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 321. BRICS Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 322. BRICS Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 323. BRICS Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 324. BRICS Monkeypox Rapid Test Kit Market Size, by CRISPR-based Detection, 2017-2032 (USD Million)
TABLE 325. BRICS Monkeypox Rapid Test Kit Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 326. BRICS Monkeypox Rapid Test Kit Market Size, by Lesion Swab, 2017-2032 (USD Million)
TABLE 327. BRICS Monkeypox Rapid Test Kit Market Size, by Whole Blood, 2017-2032 (USD Million)
TABLE 328. BRICS Monkeypox Rapid Test Kit Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 329. BRICS Monkeypox Rapid Test Kit Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. BRICS Monkeypox Rapid Test Kit Market Size, by Screening and Surveillance, 2017-2032 (USD Million)
TABLE 331. BRICS Monkeypox Rapid Test Kit Market Size, by Outbreak Management, 2017-2032 (USD Million)
TABLE 332. BRICS Monkeypox Rapid Test Kit Market Size, by End User, 2017-2032 (USD Million)
TABLE 333. BRICS Monkeypox Rapid Test Kit Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 334. BRICS Monkeypox Rapid Test Kit Market Size, by Clinics, 2017-2032 (USD Million)
TABLE 335. BRICS Monkeypox Rapid Test Kit Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 336. G7 Monkeypox Rapid Test Kit Market Size, by Group, 2017-2032 (USD Million)
TABLE 337. G7 Monkeypox Rapid Test Kit Market Size, by Test Technology, 2017-2032 (USD Million)
TABLE 338. G7 Monkeypox Rapid Test Kit Market Size, by Lateral Flow Immunoassay, 2017-2032 (USD Million)
TABLE 339. G7 Monkeypox Rapid Test Kit Market Size, by Isothermal Nucleic Acid Amplification, 2017-2032 (USD Million)
TABLE 340. G7 Monkeypox Rapid Test Kit Market Size, by Rapid Polymerase Ch

Companies Mentioned

  • Abbott Laboratories
  • ACON Biotech Co., Ltd.
  • Altona Diagnostics GmbH
  • Becton, Dickinson and Company
  • Beijing Hotgen Biotech Co., Ltd.
  • BGI Group
  • BioChain Science-Technology, Inc.
  • Bioperfectus Technologies Co., Ltd.
  • DaAn Gene Co., Ltd.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • Joysbio Biotechnology Co., Ltd.
  • Novacyt S.A.
  • Revvity, Inc.
  • Roche Diagnostics
  • Sansure Biotech Inc.
  • Shanghai ZJ Bio-Tech Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Trivitron Healthcare Pvt. Ltd.
  • Zhejiang Orient Gene Biotech Co., Ltd.

Related Topics

Related Reports

Food Safety Rapid Test Kit Market - Global Forecast 2026-2032 - Product Image

Food Safety Rapid Test Kit Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
PCT Rapid Test Kits Market - Global Forecast 2026-2032 - Product Image

PCT Rapid Test Kits Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Point-of-Care/Rapid Diagnostics - Global Strategic Business Report - Product Image

Point-of-Care/Rapid Diagnostics - Global Strategic Business Report

  • Report
  • 448 Pages
  • Global
From
Rapid Test Kit Patent Landscape Report 2026 Edition - Product Image

Rapid Test Kit Patent Landscape Report 2026 Edition

  • Report
  • 400 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Rapid Test Kits Market - Global Strategic Business Report - Product Image

Human Immunodeficiency Virus (HIV) Rapid Test Kits Market - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.